Most People Would Take A Blood Test For Alzheimer's, Study Says

Follow Drugslib on

By Dennis Thompson HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on April 17, 2026.

via HealthDay

FRIDAY, April 17, 2026 — Most people would want to take a blood test that can assess their risk of Alzheimer’s disease, rather than remain anxious about their odds, a new study says.

About 85% of primary care patients said they’d take a blood test that looks for the toxic proteins linked to Alzheimer’s, according to a report published April 15 in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.

These patients said they were interested even though nearly 3 out of 4 (73%) said they expect a positive test would cause them emotional distress.

That’s because anxiety over Alzheimer’s can be overwhelming, lead researcher Andrea Russell, a psychologist at Northwestern University in Chicago, said in a news release.

Russell treats people with early cognitive impairment, and sees how a missed word or a forgotten appointment can spark dread over Alzheimer’s.

“I see patients whose lives start to get smaller,” Russell said. “Some are afraid to leave the house because they worry they’ll forget something or get lost. Others don’t want to know what’s happening because there is so much doom and gloom around Alzheimer’s. For many people, it feels like the new cancer diagnosis.”

Alzheimer’s affects an estimated 7.2 million older adults in the U.S., and that number is projected to double by 2060, researchers said in background notes.

A couple of Alzheimer’s blood tests have received clearance from the U.S. Food and Drug Administration (FDA) for people 55 and older with symptoms of the degenerative brain disease, researchers said in background notes.

The tests look for levels of amyloid and tau proteins in a person’s bloodstream. Those proteins are known to form plaques and tangles in the brains of people with Alzheimer’s.

Word hasn’t gotten around about them yet. Results found that about 84% of patients were unaware such tests existed.

“These tests aren’t ready for widespread use, but they soon could be,” Russell said. “As researchers, we strive for care that centers on the needs of the patient first, so it’s important for us to know what they think about those tests.”

To assess how ready people are for these tests, researchers surveyed nearly 600 primary care patients participating in three ongoing Chicago-area studies. All were 21 or older with at least one chronic health problem.

In the survey, participants were given brief education on the tests. They were informed that the tests identify higher risk, but do not provide a definitive diagnosis of Alzheimer’s.

Results showed that:

  • 94% said it was important to offer the tests to patients with memory or thinking problems.
  • 85% said they would agree to testing if recommended by their clinician.
  • 60% said it was “very important” to offer yearly testing to adults 65 and older, even though such screening is not currently recommended.

    • “Patients and families are often dissatisfied with delays in receiving diagnoses for cognitive problems and feeling unsure what to do,” Russell said. “They don’t know whether their perceived cognitive impairment is an unrelated health issue, normal aging or dementia not diagnosed yet.”

    People said they wouldn’t take positive results lying down. Nearly 9 in 10 (87%) said they’re prepared to take the steps necessary to protect their brain health.

    “What’s healthy for the brain is healthy for the body,” Russell said. “If people learn they may be at higher risk, they may want to take action, such as managing chronic conditions, improving nutrition and staying engaged with their medical care. Those steps could help them prolong independence and well-being.”

    The top barriers to getting the test were cost (49%); concerns about test reliability (35%); fear of a positive result (22%); and concern about being treated differently after a positive result (24%).

    Sources

  • Northwestern University, news release, April 15, 2026

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2026-04-18 01:55

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords